Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Müller

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|March 27, 2013
The effects of interleukin-6 signal blockade on immune system, reproductive and skeletal development in juvenile miceTakayuki Sakurai, Ryo Takai, Heinrich Bürgin, et al.
Biomedicines|September 28, 2021
Enisamium Inhibits SARS-CoV-2 RNA SynthesisStefano Elli, Denisa Bojkova, Marco Bechtel, et al.
British Journal of Clinical Pharmacology|October 11, 2018
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifierStefan Sturm, Andreas Günther, Birgit Jaber, et al.
Mutation Research|September 22, 2010
Strategies in case of positive in vivo results in genotoxicity testingVéronique Thybaud, James T Macgregor, Lutz Müller, et al.
Toxicology|August 9, 2005
Towards the creation of an international toxicology information centrePhilip N Judson, Paul A Cooke, Nancy G Doerrer, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|May 9, 2015
IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human riskJames T MacGregor, Roland Frötschl, Paul A White, et al.
Regulatory Toxicology and Pharmacology : RTP|May 15, 2013
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impuritiesAndreas Sutter, Alexander Amberg, Scott Boyer, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|May 9, 2015
IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs)James T MacGregor, Roland Frötschl, Paul A White, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Amorfrutins are potent antidiabetic dietary natural productsChristopher Weidner, Jens C de Groot, Aman Prasad, et al.
Paediatric Anaesthesia|June 14, 2020
Impact of clear fluid fasting on pulmonary aspiration in children undergoing general anesthesia: Results of the German prospective multicenter observational (NiKs) studyChristiane E Beck, Diana Rudolph, Christoph Mahn, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|March 27, 2013
The effects of interleukin-6 signal blockade on immune system, reproductive and skeletal development in juvenile miceTakayuki Sakurai, Ryo Takai, Heinrich Bürgin, et al.
Biomedicines|September 28, 2021
Enisamium Inhibits SARS-CoV-2 RNA SynthesisStefano Elli, Denisa Bojkova, Marco Bechtel, et al.
British Journal of Clinical Pharmacology|October 11, 2018
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifierStefan Sturm, Andreas Günther, Birgit Jaber, et al.
Mutation Research|September 22, 2010
Strategies in case of positive in vivo results in genotoxicity testingVéronique Thybaud, James T Macgregor, Lutz Müller, et al.
Toxicology|August 9, 2005
Towards the creation of an international toxicology information centrePhilip N Judson, Paul A Cooke, Nancy G Doerrer, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|May 9, 2015
IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human riskJames T MacGregor, Roland Frötschl, Paul A White, et al.
Regulatory Toxicology and Pharmacology : RTP|May 15, 2013
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impuritiesAndreas Sutter, Alexander Amberg, Scott Boyer, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|May 9, 2015
IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs)James T MacGregor, Roland Frötschl, Paul A White, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Amorfrutins are potent antidiabetic dietary natural productsChristopher Weidner, Jens C de Groot, Aman Prasad, et al.
Paediatric Anaesthesia|June 14, 2020
Impact of clear fluid fasting on pulmonary aspiration in children undergoing general anesthesia: Results of the German prospective multicenter observational (NiKs) studyChristiane E Beck, Diana Rudolph, Christoph Mahn, et al.
Pageof 7